Cell rejuvenation tech is a gambit to slow aging.
“Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain.” This article in Scientific American profiles the billionaire-backed Calico Life Sciences, Life Biosciences, and Turn Biotechnologies. | learn more